Objectives To understand variability in modified Rankin Scale scores from discharge to 90 days in acute ischaemic stroke patients following treatment, and examine prediction of 90-day modified Rankin Scale score by using discharge modified Rankin Scale and discharge disposition.Materials and methods Retrospective analysis of acute ischaemic stroke patients following treatment was performed from January 2016 to March 2020. Data collection included demographic and clinical characteristics and outcomes data (modified Rankin Scale score at discharge, 30 days and 90 days and discharge disposition). Pearson’s χ2 test assessed statistical differences in distribution of modified Rankin Scale scores at discharge, 30 days and 90 days. The predictive ...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
BACKGROUND/OBJECTIVE: This study compares the global disability status of patients who had a mild is...
Background: Historically, most acute stroke clinical trials were neutral statistically, with trials ...
Introduction Shortening the time from stroke onset to treatment increases the effectiveness of endov...
Introduction: The modified Rankin Score (mRS) collected at approximately 90 days after stroke onset ...
<p>Distribution of modified Rankin Scales scores at 3 months in patients with mild stroke and treate...
Abstract Disability in patients with acute stroke varies over time, with the prediction of outcomes ...
<p>Abbreviations: NIHSS = National Institutes of Health Stroke Scale; OR = Odd's ratio; CI = c...
<p>Proportions of patients after hospital admission, 30 days and 1 to 3 years in Joinville, 2008 to ...
BACKGROUND:Acute stroke results in functional disability measurable using the well-known Barthel Ind...
Introduction: A more than one third of stroke survivors are left with permanent disability in the fo...
BackgroundAcute stroke results in functional disability measurable using the well-known Barthel Inde...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Purpose: The aim of this study was to identify whether diastolic dysfunction predicts death at 90 da...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
BACKGROUND/OBJECTIVE: This study compares the global disability status of patients who had a mild is...
Background: Historically, most acute stroke clinical trials were neutral statistically, with trials ...
Introduction Shortening the time from stroke onset to treatment increases the effectiveness of endov...
Introduction: The modified Rankin Score (mRS) collected at approximately 90 days after stroke onset ...
<p>Distribution of modified Rankin Scales scores at 3 months in patients with mild stroke and treate...
Abstract Disability in patients with acute stroke varies over time, with the prediction of outcomes ...
<p>Abbreviations: NIHSS = National Institutes of Health Stroke Scale; OR = Odd's ratio; CI = c...
<p>Proportions of patients after hospital admission, 30 days and 1 to 3 years in Joinville, 2008 to ...
BACKGROUND:Acute stroke results in functional disability measurable using the well-known Barthel Ind...
Introduction: A more than one third of stroke survivors are left with permanent disability in the fo...
BackgroundAcute stroke results in functional disability measurable using the well-known Barthel Inde...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
Purpose: The aim of this study was to identify whether diastolic dysfunction predicts death at 90 da...
Background and Purpose- The modified Rankin Scale (mRS) at 3 months is the most commonly used primar...
BACKGROUND/OBJECTIVE: This study compares the global disability status of patients who had a mild is...
Background: Historically, most acute stroke clinical trials were neutral statistically, with trials ...